Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Terry P. Gould currently holds 15,000 shares of Corvus Pharmaceuticals, Inc. (CRVS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Terry P. Gould has been a net buyer of CRVS stock. They have purchased $12.4M and sold $0 worth of shares.
Terry P. Gould's most recent insider trade was on Jun 13, 2024, when they sold 15,000 shares at $0.00 per share.
Terry P. Gould serves as Executive at Corvus Pharmaceuticals, Inc. (CRVS). They have executed 107 insider transactions totaling $12.4M over their tenure at the company.
Terry P. Gould holds the position of Executive at Corvus Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Terry P. Gould has shown a buying trading pattern, with $12.4M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Terry P. Gould was on Mar 12, 2018, when they purchased $2.0M worth of CRVS shares. This transaction involved 236,128 shares at $8.50 per share.
Terry P. Gould currently owns 15,000 shares of Corvus Pharmaceuticals, Inc. (CRVS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Terry P. Gould's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Terry P. Gould has 107 Form 4 filings on record as an insider at Corvus Pharmaceuticals, Inc..
Set alerts for Terry P. Gould and 40,000+ other insiders.